Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. - sprookjes - yvandenbroek - TriplyDB

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

http://www.wikidata.org/entity/Q34312428

about

Population Genetics and Reproductive Strategies of African Trypanosomes: Revisiting Available Published Data Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda Epidemiology of human African trypanosomiasis Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire ATPaseTb2, a unique membrane-bound FoF1-ATPase component, is essential in bloodstream and dyskinetoplastic trypanosomes Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome Trypanosoma brucei gambiense Infections in Mice Lead to Tropism to the Reproductive Organs, and Horizontal and Vertical Transmission Motility and more: the flagellum of Trypanosoma brucei.Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sickness Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis Monitoring the elimination of human African trypanosomiasis: Update to 2014 APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease development Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.Epidemiology of sleeping sickness in Boffa (Guinea): where are the trypanosomes?The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes.Genetic dissection of drug resistance in trypanosomes The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense.Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa.Incorporating scale dependence in disease burden estimates: the case of human African trypanosomiasis in Uganda Human African trypanosomiasis presenting at least 29 years after infection--what can this teach us about the pathogenesis and control of this neglected tropical disease?Tsetse Control and Gambian Sleeping Sickness; Implications for Control Strategy.A novel high-throughput activity assay for the Trypanosoma brucei editosome enzyme REL1 and other RNA ligases Molecular evidence of a Trypanosoma brucei gambiense sylvatic cycle in the human african trypanosomiasis foci of Equatorial Guinea Extracellular-signal regulated kinase 8 of Trypanosoma brucei uniquely phosphorylates its proliferating cell nuclear antigen homolog and reveals exploitable properties.The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei.Evaluating long-term effectiveness of sleeping sickness control measures in Guinea.Treatment options for second-stage gambiense human African trypanosomiasis.Is vector control needed to eliminate gambiense human African trypanosomiasis?Glossina palpalis palpalis populations from Equatorial Guinea belong to distinct allopatric clades.An Overview of Trypanosoma brucei Infections: An Intense Host-Parasite Interaction.Drug discovery and human African trypanosomiasis: a disease less neglected?The Impact of Nurses on Neglected Tropical Disease Management.A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome.How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?The within-host dynamics of African trypanosome infections.Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.

P2860

Q26780474-DEB37BF3-0D15-40D2-9DCC-A2C5279BA05D Q26825682-A1F2DD40-CE76-40E7-BC7E-DE4234067AEA Q27012611-27B6C17C-2B71-46DB-8FA5-4815369F426B Q27026504-C79D4CBC-CC3C-48A0-8442-0FC82D463FD3 Q27317424-D7343AB4-1607-4155-A61B-6B7528D1B37E Q27926217-8F7B1E27-ACDA-475F-A52F-8E05A0CE3EE7 Q28543675-02EC1E38-58BC-41D1-B0F1-2590B8CDB302 Q28551770-B0E16A41-7FAC-468C-8DA3-76EA72A54037 Q28552110-169802D1-9574-4607-A68F-9C479374091D Q30611967-872A4297-9EF4-47A2-94AD-81660F42F37E Q33748367-ABE9BD92-11B8-41D0-BB3C-2B4EEEE55AFA Q33751576-9D90E279-D9C6-4303-B865-4B2B90FC2D7F Q33758003-95F796E7-75A1-4864-B304-A55984E0157D Q33866444-92388554-5891-46D4-BD3F-FDDF11183956 Q34466454-3BFE9D38-BB91-4A5B-B7D7-E3D4591388A1 Q34474577-919F202D-151B-4BF0-BCBF-39D04B98F2C4 Q34526240-BAC0CFDF-6FD8-4935-B8F6-8DF81D4BA6AE Q34540864-F1A0342E-9431-496E-AC1E-654A2ACFC2CB Q34647009-1F654623-E471-4733-9584-7E09CDE25D28 Q34796896-DFB7FEE5-C3C1-482E-9946-CB3F0CF019C6 Q35008824-88708A0E-A916-4791-93EC-21E142D35527 Q35039193-F4A6E039-CAF7-41BE-B865-50EE489E8522 Q35097828-A4C2CC50-8978-4447-9CAC-89E481E91CBD Q35529820-764EAAF8-C8B1-4826-B48F-65BA560FE452 Q35744138-05B75E43-C3DA-4FB4-A313-BD04CDBC2371 Q35785916-2EDB8107-B300-49CC-AB72-6FCBFC8936C4 Q35884212-0CDEBAB5-B00A-43A3-BA47-6A47A7382A42 Q36121762-D96886D9-5801-43F2-B21B-53C60C98EE62 Q36153041-106A9F5A-FB38-46A8-ACDB-C21BBE914594 Q36201259-73373517-5F98-4000-B24E-21EB406A5615 Q36551049-D2548BD2-9892-49B9-8E12-BA8B317062FB Q37057698-C093D100-A75D-4594-8149-2FA6C5BD6D43 Q37504364-0DA2815F-0882-442B-B1D9-670778ED7820 Q37531559-8F789844-464D-4E16-A712-59AA30CC9478 Q38154344-4EEE1E41-3F89-40BE-853D-3BC1408C6713 Q38250382-59B8C7DF-B3B8-44F4-9E58-E17433E6D325 Q38345868-B6F6F17C-8477-45EA-815B-3BA1B6644846 Q38383077-093F3EC5-BD5E-4489-AEE3-E86054977609 Q38543502-04C3D4D0-D381-4423-AD64-4C968D71707C Q38615202-4FA14A6A-5D58-46AF-B129-9C9DF76244E1

P2860

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

http://www.wikidata.org/entity/Q34312428

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@ast

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@en

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@nl

type

label

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@ast

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@en

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@nl

prefLabel

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@ast

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@en

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@nl

P1433

Q34312428-6BF96D72-5E23-45B8-BB66-ECE13B4F1B1A

P1476

Q34312428-E116101F-654A-4E8D-B8DF-045E38CEF42C

P2093

Q34312428-2B15D6DD-0DD1-4B2E-9B5A-64ED3BD67682

Q34312428-3AF0BEC4-B49F-4F00-BAAF-74A3B339D3C0

Q34312428-5AF77AB7-02B9-44C0-AD73-C96F688E51F3

Q34312428-5DD9D6E8-7BE9-474B-A26B-423D81834CAF

Q34312428-6CDA7A14-A730-436D-8D04-E899135024F8

Q34312428-77DB4A57-8FCD-4026-9C84-0B48D7F0AE39

Q34312428-7EAA8950-035E-48B1-9ACA-E1AF55E69401

Q34312428-A4047EFF-1C93-48C4-A957-50B89603F390

Q34312428-E7B0BE8F-10B0-4137-93C8-4F30608F5467

P275

Q34312428-902EE3C7-AE70-4FC0-A165-FD392487B125

P2860

Q34312428-03DA3365-C5ED-4395-98DD-163559E9230B

Q34312428-0653BA2C-4B22-4CC8-BE8E-D53BB23F57AD

Q34312428-154B7AAC-28FF-42C3-B88B-D4974AC86E07

Q34312428-1A4E757A-BD1C-489D-98BD-5DD1881A083E

Q34312428-2084CA5D-CC8E-4EE3-B1BF-6142335EEBF4

Q34312428-23640FAA-1B73-4178-A837-99CBFA159F9A

Q34312428-277B82EE-C983-48AE-A40D-CDCDD60D971B

Q34312428-2B6162B6-8E81-4637-B21B-9F3BB832081C

Q34312428-35FFD1B0-F037-4735-9275-1BFFF73B2CC8

Q34312428-36B9B2F1-3501-440E-AE72-D054D2E890C1

P304

Q34312428-60507864-041E-4C77-BFAB-50C05AA60CA9

P31

Q34312428-C5343094-D98D-4CF7-9EF8-4D39B009A91E

P356

Q34312428-0E8A9E72-FFBB-4277-8B75-713C0531C8B6

P407

Q34312428-1980C5D5-86D9-48CD-9A7C-C48D64BB3C9F

P433

Q34312428-13D1EF4A-6736-4E94-ADBD-9E54A02F085D

P478

Q34312428-DBD8C911-5E70-4F7A-BEF1-3BDBE5257351

P50

Q34312428-109A5C8F-3728-40F6-87BF-00C96124976B

Q34312428-5283402E-791C-435F-A2E6-90589F0EB0B5

Q34312428-F0DB2920-D4F5-44CD-9CB5-3CC10737246B

P5008

Q34312428-CB79C805-82B5-4515-BE91-FE2EE299EE2A

P577

Q34312428-B0FB99A6-3E8E-4AE9-BE4E-DC487FA8A438

P5875

Q34312428-A310FE9A-3E94-4D40-8AC1-C06CB77B98D6

P698

Q34312428-04C589B9-09B4-40F1-9C89-3DB9FB7B7087

P921

Q34312428-77456D55-943F-478E-BEDC-096AC296F4E3

Q34312428-A5616D5D-6F2C-44AC-9906-8C285B8A636E

P932

Q34312428-32589357-6F20-48FC-B2C3-BDDB645C5EE9

P356

JOURNAL.PNTD.0001691

P1433

PLOS Neglected Tropical Diseases

P1476

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

@en

P2093

André Garcia

http://www.w3.org/2001/XMLSchema#string

Bruno Bucheton

http://www.w3.org/2001/XMLSchema#string

Claude Laveissière

http://www.w3.org/2001/XMLSchema#string

Dramane Kaba

http://www.w3.org/2001/XMLSchema#string

Hamidou Ilboudo

http://www.w3.org/2001/XMLSchema#string

Jacques Kaboré

http://www.w3.org/2001/XMLSchema#string

Kouakou Lingue

http://www.w3.org/2001/XMLSchema#string

Mathurin Koffi

http://www.w3.org/2001/XMLSchema#string

Vincent Jamonneau

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Options for field diagnosis of human african trypanosomiasis

The history of African trypanosomiasis

Estimates of the duration of the early and late stage of gambiense sleeping sickness

Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for sleeping sickness diagnosis and staging.

The natural progression of Gambiense sleeping sickness: what is the evidence?

Murine Models for Trypanosoma brucei gambiense disease progression--from silent to chronic infections and early brain tropism

A CATT negative result after treatment for human African trypanosomiasis is no indication for cure.

Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa.

Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study.

P304

e1691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0001691

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Solano

Philippe Büscher

P5008

P577

2012-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227712758

http://www.w3.org/2001/XMLSchema#string

P698

22720107

http://www.w3.org/2001/XMLSchema#string

P921

Trypanosoma brucei gambiense infectious disease

Trypanosoma brucei

P932

3373650

http://www.w3.org/2001/XMLSchema#string